Literature DB >> 11767219

Management of prolonged pregnancy: a randomized trial of induction of labour and antepartum foetal monitoring.

C James1, S S George, N Gaunekar, L Seshadri.   

Abstract

BACKGROUND: The two methods of management of prolonged pregnancy, induction of labour and expectant management with foetal surveillance, have pros and cons. Therefore, we compared the induction of labour with serial antenatal foetal monitoring in the management of post-term pregnancy.
METHODS: Seventy-four women with uncomplicated pregnancy at 41 weeks (287 days) of gestation were randomly assigned to undergo either induction of labour or serial antenatal foetal monitoring. Labour was induced in the latter group whenever there was evidence of foetal compromise. Antenatal monitoring consisted of the foetal kick count, non-stress test and biophysical profile.
RESULTS: Fifty-seven per cent of women went into spontaneous labour by 41 weeks and 4 days (291 days) of gestation and only 14% developed foetal compromise before that. However, when the gestational age was more than 41 weeks and 4 days (291 days), the incidence of meconium staining of amniotic fluid and evidence of uteroplacental insufficiency increased significantly. The rate of caesarean section, instrumental delivery, foetal distress and duration of labour did not differ significantly between the two groups.
CONCLUSION: The policy of inducing labour at 41 weeks and 4 days (291 days of gestation) in uncomplicated pregnancies is justified in our population. However, foetal monitoring should begin at 41 weeks of gestation.

Entities:  

Mesh:

Year:  2001        PMID: 11767219

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  10 in total

Review 1.  Caesarean Delivery Rate Review: An Evidence-Based Analysis.

Authors:  N Degani; N Sikich
Journal:  Ont Health Technol Assess Ser       Date:  2015-03-01

2.  Induction of Labour in Late and Postterm Pregnancies and its Impact on Maternal and Neonatal Outcome.

Authors:  F Thangarajah; P Scheufen; V Kirn; P Mallmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-07       Impact factor: 2.915

Review 3.  Induction of labour for improving birth outcomes for women at or beyond term.

Authors:  A Metin Gülmezoglu; Caroline A Crowther; Philippa Middleton; Emer Heatley
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 4.  Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis.

Authors:  Ekaterina Mishanina; Ewelina Rogozinska; Tej Thatthi; Rehan Uddin-Khan; Khalid S Khan; Catherine Meads
Journal:  CMAJ       Date:  2014-04-28       Impact factor: 8.262

Review 5.  Biophysical profile for fetal assessment in high risk pregnancies.

Authors:  J G Lalor; B Fawole; Z Alfirevic; D Devane
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

6.  Induction of labour at or beyond 37 weeks' gestation.

Authors:  Philippa Middleton; Emily Shepherd; Jonathan Morris; Caroline A Crowther; Judith C Gomersall
Journal:  Cochrane Database Syst Rev       Date:  2020-07-15

Review 7.  Elective induction for pregnancies at or beyond 41 weeks of gestation and its impact on stillbirths: a systematic review with meta-analysis.

Authors:  Arwa Abbas Hussain; Mohammad Yawar Yakoob; Aamer Imdad; Zulfiqar A Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

Review 8.  Postterm pregnancy.

Authors:  M Galal; I Symonds; H Murray; F Petraglia; R Smith
Journal:  Facts Views Vis Obgyn       Date:  2012

9.  A systematic scoping review of clinical indications for induction of labour.

Authors:  Dominiek Coates; Angela Makris; Christine Catling; Amanda Henry; Vanessa Scarf; Nicole Watts; Deborah Fox; Purshaiyna Thirukumar; Vincent Wong; Hamish Russell; Caroline Homer
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

Review 10.  Induction of labour for improving birth outcomes for women at or beyond term.

Authors:  Philippa Middleton; Emily Shepherd; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.